JP2009526754A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526754A5
JP2009526754A5 JP2008549107A JP2008549107A JP2009526754A5 JP 2009526754 A5 JP2009526754 A5 JP 2009526754A5 JP 2008549107 A JP2008549107 A JP 2008549107A JP 2008549107 A JP2008549107 A JP 2008549107A JP 2009526754 A5 JP2009526754 A5 JP 2009526754A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
agent
nanostructure
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2008549107A
Other languages
English (en)
Other versions
JP2009526754A (ja
Filing date
Publication date
Priority claimed from US11/324,586 external-priority patent/US20060177852A1/en
Application filed filed Critical
Priority claimed from PCT/IL2007/000014 external-priority patent/WO2007077561A2/en
Publication of JP2009526754A publication Critical patent/JP2009526754A/ja
Publication of JP2009526754A5 publication Critical patent/JP2009526754A5/ja
Abandoned legal-status Critical Current

Links

Claims (13)

  1. (a)有効成分としての少なくとも1つの医薬剤と、
    (b)ナノ構造と、液体と
    を含み、前記ナノ構造は、前記液体の整列した流体分子によって包まれたナノメートルサイズのコア材料を含み、前記コア材料、および、前記整列した流体分子のエンベロープが定常的な物理的状態にあり、ただし、前記ナノ構造および液体は、前記少なくとも1つの医薬剤のインビボ取り込みを高めるために配合される、医薬組成物。
  2. 医薬剤は、治療剤、化粧剤または診断剤である、請求項1に記載の医薬組成物。
  3. 前記医薬剤は、タンパク質薬剤、核酸薬剤、小分子薬剤、細胞性薬剤およびそれらの組合せからなる群より選択される、請求項1に記載の医薬組成物。
  4. 前記タンパク質薬剤はペプチドである、請求項3に記載の医薬組成物。
  5. 前記タンパク質薬剤は、酵素、増殖因子、ホルモンおよび抗体からなる群より選択される、請求項3に記載の医薬組成物。
  6. 前記細胞性薬剤はウイルスである、請求項3に記載の医薬組成物。
  7. 前記診断剤は造影剤である、請求項2に記載の医薬組成物。
  8. 前記ナノ構造はヒドロキシアパタイトから配合される、請求項1に記載の医薬組成物。
  9. 前記治療剤は、皮膚の状態を処置するために選択される、請求項2に記載の医薬組成物。
  10. 局所用組成物で配合される、請求項1に記載の医薬組成物。
  11. 医薬剤は、脳の状態を処置または診断するために選択される、請求項1に記載の医薬組成物。
  12. (a)有効成分としてのタキソールと、(b)ナノ構造および液体とを含む医薬組成物であって、前記ナノ構造は、前記液体の整列した流体分子によって包まれたナノメートルサイズのコア材料を含み、前記コア材料、および、前記整列した流体分子のエンベロープが定常的な物理的状態にある、医薬組成物。
  13. 経口送達のために配合される、請求項12に記載の医薬組成物。
JP2008549107A 2006-01-04 2007-01-04 医薬剤のインビボ取り込みを強化するための組成物および方法 Abandoned JP2009526754A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US75585206P 2006-01-04 2006-01-04
US75585006P 2006-01-04 2006-01-04
US75585106P 2006-01-04 2006-01-04
US11/324,586 US20060177852A1 (en) 2001-12-12 2006-01-04 Solid-fluid composition
PCT/IL2007/000014 WO2007077561A2 (en) 2006-01-04 2007-01-04 Compositions and methods for enhancing in-vivo uptake of pharmaceutical agents

Publications (2)

Publication Number Publication Date
JP2009526754A JP2009526754A (ja) 2009-07-23
JP2009526754A5 true JP2009526754A5 (ja) 2010-02-04

Family

ID=39735923

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2008549107A Abandoned JP2009526754A (ja) 2006-01-04 2007-01-04 医薬剤のインビボ取り込みを強化するための組成物および方法
JP2008549108A Abandoned JP2009523128A (ja) 2006-01-04 2007-01-04 殺菌組成物及びそれを使用する方法
JP2008549109A Abandoned JP2009524600A (ja) 2006-01-04 2007-01-04 固液組成物
JP2008549106A Abandoned JP2009521949A (ja) 2006-01-04 2007-01-04 凍結保護組成物およびその使用方法

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2008549108A Abandoned JP2009523128A (ja) 2006-01-04 2007-01-04 殺菌組成物及びそれを使用する方法
JP2008549109A Abandoned JP2009524600A (ja) 2006-01-04 2007-01-04 固液組成物
JP2008549106A Abandoned JP2009521949A (ja) 2006-01-04 2007-01-04 凍結保護組成物およびその使用方法

Country Status (7)

Country Link
US (1) US20090029340A1 (ja)
EP (4) EP1981988A2 (ja)
JP (4) JP2009526754A (ja)
KR (4) KR20080098600A (ja)
AU (4) AU2007203960A1 (ja)
CA (4) CA2635978A1 (ja)
WO (4) WO2007077563A2 (ja)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060177852A1 (en) * 2001-12-12 2006-08-10 Do-Coop Technologies Ltd. Solid-fluid composition
US20090253613A1 (en) * 2006-01-04 2009-10-08 Do-Coop Technologies Ltd. Solid-Fluid Composition
US20090004296A1 (en) * 2006-01-04 2009-01-01 Do-Coop Technologies Ltd. Antiseptic Compositions and Methods of Using Same
CA2674123A1 (en) * 2007-01-04 2008-07-10 Do-Coop Technologies Ltd. Composition and method for enhancing cell growth and cell fusion
CA2674118A1 (en) * 2007-01-04 2008-07-10 Do-Coop Technologies Ltd. Detection of analytes
GB0705626D0 (en) * 2007-03-23 2007-05-02 Royal Veterinary College Method for enhancing sperm survival
EP2197462A2 (en) * 2007-09-11 2010-06-23 Mondobiotech Laboratories AG Use of il-1 receptor peptide, alone or in combination with d-ala-gln-octadecyl ester, as a therapeutic agent
US20100204111A1 (en) * 2007-09-11 2010-08-12 Dorian Bevec Astressin and beta- endorphin for use as therapeutic agents
US20090081785A1 (en) 2007-09-24 2009-03-26 Hememics Biotechnologies, Inc. Desiccated Biologics And Methods Of Preparing The Same
CA2705107C (en) * 2007-11-09 2014-07-15 Praxair Technology, Inc. Method and system for controlled rate freezing of biological material
US20100285141A1 (en) * 2008-01-03 2010-11-11 Do-Coop Technologies Ltd. Compositions and methods for enhancing the activity of podophyllotoxin
AR071478A1 (es) 2008-04-17 2010-06-23 Baxter Healthcare Sa Peptidos de bajo peso molecular con actividad procoagulante para el tratamiento de pacientes con deficiencia de factor v (fv), fvii, fviii, fx y/o fxi
US20100209540A1 (en) * 2008-11-05 2010-08-19 Pharmacaribe Inhalation formulation for treating and prophylactic use in bacteria, mycobacterial and fungal respiratory infections
EP2395985B1 (en) 2009-02-11 2016-07-27 Ramot at Tel-Aviv University Ltd. Antiseptic compositions comprising silver ions and menthol and uses thereof
US9700038B2 (en) 2009-02-25 2017-07-11 Genea Limited Cryopreservation of biological cells and tissues
KR101092411B1 (ko) * 2009-07-22 2011-12-09 (주)시지바이오 이식용 동종 피부의 처리 방법 및 그로부터 제조된 동결보존동종피부
EP2301943B1 (en) * 2009-09-08 2014-01-08 Heraeus Precious Metals GmbH & Co. KG Crystallization of epidaunorubicin x HCI
US8445439B2 (en) 2009-10-23 2013-05-21 University Of Occupational And Environmental Health, Japan Itch suppressant
US9943075B2 (en) * 2010-02-17 2018-04-17 Hememics Biotechnologies, Inc. Preservation solutions for biologics and methods related thereto
US8529883B2 (en) * 2010-05-07 2013-09-10 Fibrocell Technologies, Inc. Dosage unit formulations of autologous dermal fibroblasts
CN103179852B (zh) 2010-05-28 2015-04-08 格尼亚有限公司 改良的显微操作和储存装置以及方法
US20120128845A1 (en) * 2010-11-22 2012-05-24 Carol Ann Tosaya Ice, toxicity, thermal-stress and cold-fracture management during cryopreserving encapsulation of specimens using controlled ice nucleation
CN102206285B (zh) * 2011-04-19 2013-02-13 兰州大学 基于内吗啡肽2和神经肽ff的嵌合肽及其合成和应用
AU2012267484B2 (en) 2011-06-10 2017-03-23 Bioverativ Therapeutics Inc. Pro-coagulant compounds and methods of use thereof
US11021733B2 (en) 2011-09-26 2021-06-01 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
WO2013045458A1 (en) 2011-09-26 2013-04-04 Preanalytix Gmbh Stabilisation and isolation of extracellular nucleic acids
US20140308364A1 (en) * 2011-11-16 2014-10-16 The University Of North Carolina At Chapel Hill Gelatinous hydroxyapatite-nanocomposites
WO2013096659A1 (en) * 2011-12-20 2013-06-27 Cook General Biotechnology Llc Methods and compositions for storage of animal cells
AU2013232381B2 (en) 2012-03-14 2018-08-30 Membrane Protective Technologies, Inc. System and substances for cryopreservation of viable cells
EP3693000B1 (en) 2012-06-08 2022-03-02 Bioverativ Therapeutics Inc. Procoagulant compounds
KR101410589B1 (ko) * 2012-07-19 2014-06-20 주식회사 바이오에프디엔씨 뉴로펩타이드 유도체 및 이를 함유하는 피부 외용제 조성물
WO2014049022A1 (en) 2012-09-25 2014-04-03 Qiagen Gmbh Stabilisation of biological samples
WO2014143961A1 (en) * 2013-03-15 2014-09-18 Regents Of The University Of Minnesota Cryopreservative compositions and methods
WO2014146780A1 (en) 2013-03-18 2014-09-25 Qiagen Gmbh Stabilization and isolation of extracellular nucleic acids
JP6381628B2 (ja) * 2013-03-18 2018-08-29 キアゲン ゲーエムベーハー 生物試料の安定化
SG11201700097WA (en) * 2014-07-09 2017-02-27 Genentech Inc Ph adjustment to improve thaw recovery of cell banks
CA2962239C (en) * 2014-09-29 2024-01-02 Cook General Biotechnology Llc Uses of trehalose in cell suspensions
CN104931611A (zh) * 2015-06-03 2015-09-23 福建中烟工业有限责任公司 一种检测样品中肌醇的方法、试剂盒及其用途
CN105230610B (zh) * 2015-11-13 2017-10-27 中国科学院化学研究所 一种冷冻保存液及其制备方法和应用
CN108291250B (zh) 2015-11-20 2022-05-27 凯杰有限公司 用于稳定细胞外核酸的已灭菌组合物的制备方法
EP3416483A4 (en) 2016-02-19 2019-09-11 Regents of the University of Minnesota CRYOPROTEKING COMPOSITIONS AND METHODS
WO2017184721A1 (en) 2016-04-19 2017-10-26 Regents Of The University Of Minnesota Cryopreservation compositions and methods involving nanowarming
GB201608356D0 (en) * 2016-05-12 2016-06-29 Univ Leeds And Asymptote Ltd Formulation
JP6957615B2 (ja) * 2016-07-22 2021-11-02 ティシュー テスティング テクノロジーズ エルエルシーTissue Testing Technologies Llc 糖脂質による細胞凍結保存性の向上
WO2018227359A1 (en) * 2017-06-13 2018-12-20 Chung Chin Sun A novel method for blood serum protein activity preservation
JP6901801B2 (ja) * 2017-06-14 2021-07-14 バイオソリューション カンパニー・リミテッドBio Solution Co Ltd 物質pを含むしわの改善または抗炎症化粧料組成物
JP7072147B2 (ja) * 2018-09-13 2022-05-20 極東製薬工業株式会社 間葉系幹細胞の凍害保護液とその利用
JP7445611B2 (ja) * 2019-02-15 2024-03-07 イビデン株式会社 凍結保存液
EP3996812A1 (en) * 2019-07-31 2022-05-18 University of South Carolina Alginate-based microcapsulation for the delivery of alpha-cgrp in cardiovascular diseases
CN110720452B (zh) * 2019-11-05 2021-11-19 南通大学 一种优化病理大体标本保存的方法
CN110754464B (zh) * 2019-11-13 2021-08-10 四川仟众生物科技有限公司 一种自体颅骨深低温保存方法
KR102116954B1 (ko) * 2019-12-26 2020-05-29 주식회사 엠케이바이오텍 태아 유래 줄기세포의 동결 보존 및 동결 건조용 배지 조성물
WO2024110457A1 (en) * 2022-11-21 2024-05-30 Fraunhofer-Gesellschaft Zur Foerderung Der Angewandten Forschung E. V. Identification of cryoprotectants for cryopreservation of cells and cell aggregates
CN117378598B (zh) * 2023-12-08 2024-03-19 金宝医学科技(深圳)有限公司 一种卵母细胞冻存液及其制备方法

Family Cites Families (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690890A (en) * 1984-04-04 1987-09-01 Cetus Corporation Process for simultaneously detecting multiple antigens using dual sandwich immunometric assay
US6342039B1 (en) * 1992-08-19 2002-01-29 Lawrence A. Lynn Microprocessor system for the simplified diagnosis of sleep apnea
US6223064B1 (en) * 1992-08-19 2001-04-24 Lawrence A. Lynn Microprocessor system for the simplified diagnosis of sleep apnea
US6818199B1 (en) * 1994-07-29 2004-11-16 James F. Hainfeld Media and methods for enhanced medical imaging
US5472749A (en) * 1994-10-27 1995-12-05 Northwestern University Graphite encapsulated nanophase particles produced by a tungsten arc method
US5585020A (en) * 1994-11-03 1996-12-17 Becker; Michael F. Process for the production of nanoparticles
US7011812B1 (en) * 1996-05-03 2006-03-14 Immunomedics, Inc. Targeted combination immunotherapy of cancer and infectious diseases
IL120881A (en) * 1996-07-30 2002-09-12 It M R Medic L Cm 1997 Ltd Method and device for continuous and non-invasive monitoring of peripheral arterial tone
US6103868A (en) * 1996-12-27 2000-08-15 The Regents Of The University Of California Organically-functionalized monodisperse nanocrystals of metals
US6884842B2 (en) * 1997-10-14 2005-04-26 Alnis Biosciences, Inc. Molecular compounds having complementary surfaces to targets
US6198281B1 (en) * 1997-11-12 2001-03-06 The Research Foundation Of State University Of New York NMR spectroscopy of large proteins
US6370423B1 (en) * 1998-10-05 2002-04-09 Juan R. Guerrero Method for analysis of biological voltage signals
US6142950A (en) * 1998-12-10 2000-11-07 Individual Monitoring Systems, Inc. Non-tethered apnea screening device
US20070021979A1 (en) * 1999-04-16 2007-01-25 Cosentino Daniel L Multiuser wellness parameter monitoring system
US6608562B1 (en) * 1999-08-31 2003-08-19 Denso Corporation Vital signal detecting apparatus
US6527729B1 (en) * 1999-11-10 2003-03-04 Pacesetter, Inc. Method for monitoring patient using acoustic sensor
US6480733B1 (en) * 1999-11-10 2002-11-12 Pacesetter, Inc. Method for monitoring heart failure
US6409675B1 (en) * 1999-11-10 2002-06-25 Pacesetter, Inc. Extravascular hemodynamic monitor
US7206636B1 (en) * 1999-11-10 2007-04-17 Pacesetter, Inc. Pacing optimization based on changes in pulse amplitude and pulse amplitude variability
US6752765B1 (en) * 1999-12-01 2004-06-22 Medtronic, Inc. Method and apparatus for monitoring heart rate and abnormal respiration
US6519490B1 (en) * 1999-12-20 2003-02-11 Joseph Wiesel Method of and apparatus for detecting arrhythmia and fibrillation
US7806831B2 (en) * 2000-03-02 2010-10-05 Itamar Medical Ltd. Method and apparatus for the non-invasive detection of particular sleep-state conditions by monitoring the peripheral vascular system
AU2001251514A1 (en) * 2000-04-10 2001-10-23 The Research Foundation Of State University Of New York Method for detecting cheyne-stokes respiration in patients with congestive heart failure
US6839581B1 (en) * 2000-04-10 2005-01-04 The Research Foundation Of State University Of New York Method for detecting Cheyne-Stokes respiration in patients with congestive heart failure
US6589188B1 (en) * 2000-05-05 2003-07-08 Pacesetter, Inc. Method for monitoring heart failure via respiratory patterns
SG98393A1 (en) * 2000-05-19 2003-09-19 Inst Materials Research & Eng Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
US6480734B1 (en) * 2000-06-30 2002-11-12 Cardiac Science Inc. Cardiac arrhythmia detector using ECG waveform-factor and its irregularity
US6856829B2 (en) * 2000-09-07 2005-02-15 Denso Corporation Method for detecting physiological condition of sleeping patient based on analysis of pulse waves
SE0004417D0 (sv) * 2000-11-28 2000-11-28 St Jude Medical Implantable device
US6529752B2 (en) * 2001-01-17 2003-03-04 David T. Krausman Sleep disorder breathing event counter
US6918946B2 (en) * 2001-07-02 2005-07-19 Board Of Regents, The University Of Texas System Applications of light-emitting nanoparticles
ATE403751T1 (de) * 2001-11-09 2008-08-15 Nanosphere Inc Biokonjugat-nanopartikelsonden
WO2005079153A2 (en) * 2004-02-20 2005-09-01 Do-Coop Technologies Ltd. Solid-fluid composition and uses thereof
US20060177852A1 (en) * 2001-12-12 2006-08-10 Do-Coop Technologies Ltd. Solid-fluid composition
US6829501B2 (en) * 2001-12-20 2004-12-07 Ge Medical Systems Information Technologies, Inc. Patient monitor and method with non-invasive cardiac output monitoring
WO2003082077A2 (en) * 2002-03-26 2003-10-09 National Aeronautics And Space Administration System for the diagnosis and monitoring of coronary artery disease, acute coronary syndromes, cardiomyopathy and other cardiac conditions
US6881192B1 (en) * 2002-06-12 2005-04-19 Pacesetter, Inc. Measurement of sleep apnea duration and evaluation of response therapies using duration metrics
US6689342B1 (en) * 2002-07-29 2004-02-10 Warner-Lambert Company Oral care compositions comprising tropolone compounds and essential oils and methods of using the same
US7024234B2 (en) * 2002-09-20 2006-04-04 Lyle Aaron Margulies Method and apparatus for monitoring the autonomic nervous system
US7160252B2 (en) * 2003-01-10 2007-01-09 Medtronic, Inc. Method and apparatus for detecting respiratory disturbances
AU2003901877A0 (en) * 2003-04-16 2003-05-08 Richard Charles Clark Sleep management device
US7524292B2 (en) * 2003-04-21 2009-04-28 Medtronic, Inc. Method and apparatus for detecting respiratory disturbances
US20050266090A1 (en) * 2003-04-29 2005-12-01 Ales Prokop Nanoparticular targeting and therapy
IL155955A0 (en) * 2003-05-15 2003-12-23 Widemed Ltd Adaptive prediction of changes of physiological/pathological states using processing of biomedical signal
US20050239108A1 (en) * 2004-02-23 2005-10-27 University Of Maryland, Baltimore Immuno-PCR method for the detection of a biomolecule in a test sample
US20050191270A1 (en) * 2004-02-27 2005-09-01 Hydromer, Inc. Anti-infectious hydrogel compositions
US7413549B1 (en) * 2004-03-17 2008-08-19 Pacesetter, Inc. Detecting and quantifying apnea using ventilatory cycle histograms
JP3987053B2 (ja) * 2004-03-30 2007-10-03 株式会社東芝 睡眠状態判定装置および睡眠状態判定方法
DE102004016883A1 (de) * 2004-04-06 2005-10-27 Coripharm Medizinprodukte Gmbh & Co. Kg. Verfahren zur Herstellung eines Knochen-Implantat-materials mit verbesserter mechanischer Beanspruchbarkeit auf der Basis von Formkörpern aus porösem Implantatmaterial sowie nach dem Verfahren hergestelltes Implantatmaterial
US7276088B2 (en) * 2004-04-15 2007-10-02 E.I. Du Pont De Nemours And Company Hair coloring and cosmetic compositions comprising carbon nanotubes
US20070208269A1 (en) * 2004-05-18 2007-09-06 Mumford John R Mask assembly, system and method for determining the occurrence of respiratory events using frontal electrode array
US7578793B2 (en) * 2004-11-22 2009-08-25 Widemed Ltd. Sleep staging based on cardio-respiratory signals
US7680532B2 (en) * 2005-02-25 2010-03-16 Joseph Wiesel Detecting atrial fibrillation, method of and apparatus for
US20070149870A1 (en) * 2005-12-28 2007-06-28 Futrex, Inc. Systems and methods for determining an organism's pathology
US20090004296A1 (en) * 2006-01-04 2009-01-01 Do-Coop Technologies Ltd. Antiseptic Compositions and Methods of Using Same
US7819816B2 (en) * 2006-03-29 2010-10-26 Cardiac Pacemakers, Inc. Periodic disordered breathing detection
US20080003576A1 (en) * 2006-06-30 2008-01-03 Jingwu Zhang Assay platforms and detection methodology using surface enhanced Raman scattering (SERS) upon specific biochemical interactions
US7972691B2 (en) * 2006-12-22 2011-07-05 Nanogram Corporation Composites of polymers and metal/metalloid oxide nanoparticles and methods for forming these composites
CA2674123A1 (en) * 2007-01-04 2008-07-10 Do-Coop Technologies Ltd. Composition and method for enhancing cell growth and cell fusion
CA2674118A1 (en) * 2007-01-04 2008-07-10 Do-Coop Technologies Ltd. Detection of analytes
US20080300500A1 (en) * 2007-05-30 2008-12-04 Widemed Ltd. Apnea detection using a capnograph

Similar Documents

Publication Publication Date Title
JP2009526754A5 (ja)
Curreri et al. Recent advances in ionic liquids in biomedicine
Adepu et al. Controlled drug delivery systems: current status and future directions
Zhou et al. Advances in the application of electrospun drug-loaded nanofibers in the treatment of oral ulcers
Li et al. A G-quadruplex hydrogel via multicomponent self-assembly: formation and zero-order controlled release
Deng et al. Lamprey-teeth-inspired oriented antibacterial sericin microneedles for infected wound healing improvement
Singh et al. Drug delivery: advancements and challenges
Rabiei et al. Nanomaterial and advanced technologies in transdermal drug delivery
Lin et al. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery
WO2007040469A3 (en) Chloroquine coupled compositions and methods for their synthesis
WO2008066507A3 (en) Nanotube devices for targeted delivery of therapeutic molecules
WO2021147598A1 (zh) 含氟化合物修饰的阳离子聚合物作为药物载体的应用及制备方法
WO2008103409A3 (en) Compositions of chloroquine coupled to antibodies and to other proteins with methods for their synthesis
Zhang et al. Composite of functional mesoporous silica and DNA: an enzyme-responsive controlled release drug carrier system
Hong et al. Biocompatible conductive hydrogels: applications in the field of biomedicine
JP2014500867A5 (ja)
Pardeshi et al. Functional thermoresponsive hydrogel molecule to material design for biomedical applications
WO2009106819A3 (en) Biological materials and uses thereof
ES2397909A1 (es) Procedimiento de obtención de materiales multifuncionalizados
CA3175594A1 (en) Patch product based on natural polymers
CN104586821B (zh) 一种负载铂类药物的水凝胶体系及其制备方法
Atanasova et al. Textile materials modified with stimuli-responsive drug carrier for skin topical and transdermal delivery
Zhao et al. Microneedles: a novel strategy for wound management
Das et al. Stimuli-responsive boron-based materials in drug delivery
Li et al. Recent developments in delivery of microRNAs utilizing nanosystems for metabolic syndrome therapy